Russell Investments Group, Ltd. Spectrum Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$2.89 - $4.45 $347,337 - $534,827	-120,186 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$2.9 - $4.09 $257,467 - $363,118	-88,782 Reduced 42.49%	120,186 $390,000
Q4 2020 Feb 08, 2021	SELL	$3.38 - $5.14 $274,699 - $417,738	-81,272 Reduced 28.0%	208,968 $711,000
Q3 2020 Nov 09, 2020	BUY	$2.99 - $4.9 $337,212 - $552,622	112,780 Added 63.55%	290,240 $1.18 Million
Q2 2020 Aug 05, 2020	BUY	$2.11 - $3.38 $101,012 - $161,810	47,873 Added 36.94%	177,460 $598,000
Q1 2020 May 06, 2020	SELL	$1.83 - $3.45 $119,295 - $224,902	-65,189 Reduced 33.47%	129,587 $301,000
Q4 2019 Jan 29, 2020	BUY	$3.5 - $10.35 $119,399 - $353,079	34,114 Added 21.23%	194,776 $707,000
Q3 2019 Nov 01, 2019	BUY	$7.03 - $9.7 $1.13 Million - $1.56 Million	160,662 New	160,662 $1.34 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.